Cargando…
Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002188/ https://www.ncbi.nlm.nih.gov/pubmed/20822968 http://dx.doi.org/10.1289/ehp.1002237 |
_version_ | 1782193705611952128 |
---|---|
author | Stewart, Judith C. Chalupa, David C. Devlin, Robert B. Frasier, Lauren M. Huang, Li-Shan Little, Erika L. Lee, Steven M. Phipps, Richard P. Pietropaoli, Anthony P. Taubman, Mark B. Utell, Mark J. Frampton, Mark W. |
author_facet | Stewart, Judith C. Chalupa, David C. Devlin, Robert B. Frasier, Lauren M. Huang, Li-Shan Little, Erika L. Lee, Steven M. Phipps, Richard P. Pietropaoli, Anthony P. Taubman, Mark B. Utell, Mark J. Frampton, Mark W. |
author_sort | Stewart, Judith C. |
collection | PubMed |
description | BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 μg/m(3) elemental carbon UFP (count median diameter, 32 nm) by mouthpiece for 2 hr at rest. We repeatedly measured markers of vascular activation, coagulation, and systemic inflammation before and after exposure. RESULTS: Compared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure. Soluble CD40L decreased with UFP exposure. Plasma von Willebrand factor increased immediately after exposure. There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer. CONCLUSIONS: Inhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes. |
format | Text |
id | pubmed-3002188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-30021882010-12-16 Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes Stewart, Judith C. Chalupa, David C. Devlin, Robert B. Frasier, Lauren M. Huang, Li-Shan Little, Erika L. Lee, Steven M. Phipps, Richard P. Pietropaoli, Anthony P. Taubman, Mark B. Utell, Mark J. Frampton, Mark W. Environ Health Perspect Research BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 μg/m(3) elemental carbon UFP (count median diameter, 32 nm) by mouthpiece for 2 hr at rest. We repeatedly measured markers of vascular activation, coagulation, and systemic inflammation before and after exposure. RESULTS: Compared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure. Soluble CD40L decreased with UFP exposure. Plasma von Willebrand factor increased immediately after exposure. There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer. CONCLUSIONS: Inhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes. National Institute of Environmental Health Sciences 2010-12 2010-09-07 /pmc/articles/PMC3002188/ /pubmed/20822968 http://dx.doi.org/10.1289/ehp.1002237 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Research Stewart, Judith C. Chalupa, David C. Devlin, Robert B. Frasier, Lauren M. Huang, Li-Shan Little, Erika L. Lee, Steven M. Phipps, Richard P. Pietropaoli, Anthony P. Taubman, Mark B. Utell, Mark J. Frampton, Mark W. Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title | Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title_full | Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title_fullStr | Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title_full_unstemmed | Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title_short | Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes |
title_sort | vascular effects of ultrafine particles in persons with type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002188/ https://www.ncbi.nlm.nih.gov/pubmed/20822968 http://dx.doi.org/10.1289/ehp.1002237 |
work_keys_str_mv | AT stewartjudithc vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT chalupadavidc vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT devlinrobertb vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT frasierlaurenm vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT huanglishan vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT littleerikal vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT leestevenm vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT phippsrichardp vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT pietropaolianthonyp vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT taubmanmarkb vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT utellmarkj vasculareffectsofultrafineparticlesinpersonswithtype2diabetes AT framptonmarkw vasculareffectsofultrafineparticlesinpersonswithtype2diabetes |